Abstract
Objective
To study early motor and cognitive symptoms in Huntington disease.Design
A follow-up cohort study after a DNA test procedure in which gene carriers and noncarriers were identified among people genetically at risk for Huntington disease.Setting
Leiden University Medical Center, Department of Neurology, Leiden, the Netherlands, in cooperation with the Clinical Genetics Center Leiden and the Department of Medical Psychology and Psychotherapy, Erasmus University Rotterdam, Rotterdam, the Netherlands.Participants
Thirty-three individuals: 9 unaffected gene carriers, 6 gene carriers with motor symptoms, and 18 noncarriers of the gene for Huntington disease.Main outcome measures
A neuropsychologic examination covering a broad area of cognitive functioning, reaction time procedures, and motor tasks.Results
The neuropsychologic assessment showed no significant differences between presymptomatic gene carriers and noncarriers. Three motor tasks differentiated between these 2 groups on a liberal .05 P level (analysis of variance followed by the Student test). The affected gene carriers performed less well than the presymptomatic gene carriers and the noncarriers in 10 motor tasks and 7 cognitive tasks. These differences were significant at P < .05.Conclusion
Motor symptoms play a more prominent and unequivocal role than cognitive symptoms in early stages of Huntington disease.Full text links
Read article at publisher's site: https://doi.org/10.1001/archneur.1997.00550230030012
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1001/archneur.1997.00550230030012
Article citations
Huntington Study Group's Neuropsychology Working Group: Implementing Non-Motor Diagnostic Criteria.
Mov Disord Clin Pract, 10(12):1714-1724, 08 Nov 2023
Cited by: 0 articles | PMID: 38094638 | PMCID: PMC10715363
Review Free full text in Europe PMC
The Translational Benefits of Sheep as Large Animal Models of Human Neurological Disorders.
Front Vet Sci, 9:831838, 15 Feb 2022
Cited by: 12 articles | PMID: 35242840 | PMCID: PMC8886239
Review Free full text in Europe PMC
Site-Specific Phosphorylation of Huntingtin Exon 1 Recombinant Proteins Enabled by the Discovery of Novel Kinases.
Chembiochem, 22(1):217-231, 13 Oct 2020
Cited by: 10 articles | PMID: 32805086 | PMCID: PMC8698011
Deficit in Motor Skill Consolidation-Dependent Synaptic Plasticity at Motor Cortex to Dorsolateral Striatum Synapses in a Mouse Model of Huntington's Disease.
eNeuro, 7(2):ENEURO.0297-19.2020, 01 Mar 2020
Cited by: 7 articles | PMID: 32144144 | PMCID: PMC7139551
"Clinical Profile of Genetically Proven Huntington's Disease Patients from Eastern India".
Ann Indian Acad Neurol, 23(2):195-200, 25 Feb 2020
Cited by: 3 articles | PMID: 32189861 | PMCID: PMC7061496
Go to all (37) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers.
Arch Neurol, 56(5):563-568, 01 May 1999
Cited by: 54 articles | PMID: 10328251
Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.
JAMA Neurol, 74(11):1352-1360, 01 Nov 2017
Cited by: 9 articles | PMID: 28975278 | PMCID: PMC5710578
Early cognitive deficits in Swedish gene carriers of Huntington's disease.
Neuropsychology, 21(1):31-44, 01 Jan 2007
Cited by: 28 articles | PMID: 17201528
[Early and presymptomatic detection of Huntington chorea].
Fortschr Neurol Psychiatr, 61(1):1-21, 01 Jan 1993
Cited by: 2 articles | PMID: 8440509
Review